Monday, February 10, 2025

Logo for the University of Maryland Right Now Site
Skip to Content

A resource for media highlighting UMD experts, cutting-edge research and innovation, rankings, and breaking campus news

All News Releases

UMD Announces Appointment of 2025 MPower Professors

Seven professors from UMD and the University of Maryland, Baltimore have been appointed as part of the University of Maryland Strategic Partnership: MPowering the State

Envelope

COLLEGE PARK, Md. – The University of Maryland Strategic Partnership: MPowering the State (MPower) announces the appointment of seven professors from the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP), as 2025 MPower Professors. The MPower Professorship recognizes, incentivizes and fosters collaborations between faculty who are working together on the most pressing issues of our time.

To be considered for the MPower Professorship, faculty must demonstrate collaboration on strategic research that would be unattainable or difficult to achieve by UMB or UMCP acting independently of one another and must embrace the mission of MPower — to collectively strengthen and serve the state of Maryland and its citizens.

MPower Professors will each receive $150,000, allocated over three years, to apply to their salary or to support supplemental research activities. These funds recognize, enable and support strong collaborations between faculty in the joint research enterprise between UMCP and UMB.

“I’m deeply inspired by this incredible group of MPower Professors, who are not only dedicating themselves to solving some of the most complex problems facing society, but also embracing the power of cross-disciplinary and cross-institutional collaboration. By working together, we unlock new creative potential and develop innovative solutions that we couldn’t achieve alone,” said UMCP President Darryll J. Pines, PhD, MS. “Together, we are stronger."

“Each of the new MPower Professors demonstrates the core ideals of collaboration, innovation and real-world impact. By bringing together the expertise of our two institutions, these outstanding researchers are advancing scientific discovery and addressing critical challenges that will benefit Maryland and the broader global community," said UMB President Bruce E. Jarrell, MD, FACS.

The new cohort of MPower Professors are pushing boundaries at the intersection of data science, genomics, infectious diseases and pain research. Their endeavors range from developing advanced statistical and computational tools to analyze complex biomedical data, to investigating lateral gene transfer in pathogens, creating new anti-tick vaccines and unveiling how stress influences chronic pain. Harnessing cutting-edge methods in bioinformatics, epidemiology and public health, these researchers are shaping the future of biomedical science while informing policies and practices that improve lives.

The 2025 MPower Professors are:

Shuo Chen, PhD, is a professor in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine (UMSOM). He also serves as the director of Biostatistics and Data Science at both the University of Maryland Institute for Health Computing and the Maryland Psychiatric Research Center. A biostatistician, Dr. Chen specializes in modeling complex, structured biomedical Big data using statistical network models and machine learning/AI methods.

Dr. Chen also has broad experience in collaborative biostatistical research across medical and public health fields. As an advisor to multiple PhD students and Postdoctoral fellows from both UMCP and UMB, he is devoted to mentoring the next generation of statisticians and data scientists. Dr. Chen received his PhD from Emory University as well as a Master of Science in public health from Emory University.

Michael Cummings, PhD, is a professor in the Department of Biology in the College of Computer, Mathematical and Natural Sciences (CMNS) at UMCP and holds a joint appointment at the University of Maryland Institute for Advanced Computer Studies (UMIACS). He also serves as the director of the Center for Bioinformatics and Computational Biology. Dr. Cummings’ research involves bioinformatics and computational biology with a particular focus on data analysis that spans a broad range of biomedical problems. He takes a broadly data science approach to research with objectives including description, hypothesis generation, hypothesis testing, prediction, and uses machine learning, statistical and other methods. Dr. Cummings is a past recipient of an Alfred P. Sloan Foundation Fellowship and an NVIDIA Global Impact Award. He received his PhD from Harvard University.

Julie Dunning Hotopp, PhD, is a professor of microbiology and immunology and a scientist at the Institute for Genome Sciences at UMSOM. Dr. Dunning Hotopp’s research focuses on the understanding of the “rules of life” through the genomes and transcriptomes of multi-organismal systems, including genomics of numerous pathogens and their hosts. Her most significant scientific contribution relates to the groundbreaking documentation of extensive lateral gene transfer between symbionts and invertebrates. She was also part of a team that discovered two new Y chromosomes in dangerous filarial nematodes that cause tropical diseases that debilitate millions of people globally. Dr. Dunning Hotopp obtained her PhD in microbiology and molecular genetics from Michigan State University.

Utpal Pal, PhD, is a professor of veterinary medicine in the College of Agriculture and Natural Resources at UMCP. He also serves as a molecular and cellular biology professor for the Biological Sciences Graduate Program in CMNS. Dr. Pal’s research focuses on common tick-borne infections, primarily Lyme disease. With over 100 publications in reputed academic journals and books, he has provided professional services to federal agencies, such as the U.S. Department of Health & Human Services and the National Institutes of Health (NIH) and has a long-term collaboration with Merck & Co. to develop novel anti-tick vaccines. He earned his PhD and MS in zoology from the University of Calcutta in India. He completed postdoctoral training at the Yale University School of Medicine.

Mihai Pop, PhD, is a professor in the Department of Computer Science in CMNS and director of UMIACS. Dr. Pop’s research focuses on the development of sequence assembly algorithms and analysis of genomic data sets. His lab developed widely used computational tools for the analysis of genomic and metagenomic data. A trailblazer in the human microbiome field, Dr. Pop is also globally recognized for his efforts to diversify the computer science and computational biology communities while enhancing the international profile of microbiome research at UMB and UMCP through collaboration. Dr. Pop earned a PhD and MSE in computer science from Johns Hopkins University.

Fadia Shaya, PhD, MPH, is a UMB Distinguished University Professor in the Department of Practice, Sciences and Health Outcomes Research at the University of Maryland School of Pharmacy, as well as an affiliate professor in the Department of Epidemiology and Public Health at UMSOM. Dr. Shaya co-directs the Informatics Core, directs the Dissemination and Implementation Core in the Institute for Clinical and Translational Research and is the executive director of the Population Health Program. Her research, continuously funded externally, is based in human data science, developing methods in pharmacoeconomics, pharmacoepidemiology, public health and clinical informatics to inform practice and policy. Dr. Shaya obtained a PhD in health policy, finance and management from the Johns Hopkins Bloomberg School of Public Health, a doctoral health economics degree from the Sorbonne University Paris-IX Dauphine and an MPH from American University of Beirut.

Richard J. Traub, PhD, is a professor and chair of the Department of Neural and Pain Sciences at the University of Maryland School of Dentistry. He was an early researcher investigating the role of gonadal hormones underlying sex differences in visceral pain and the circuitry and mechanisms contributing to the transition from transient to chronic visceral pain. Most recently, his research focuses on the effects of stress on visceral and orofacial pain using animal models of chronic overlapping pain conditions. Dr. Traub served as a regular and ad hoc member for numerous NIH study sections since 2005 and a reviewer for over 25 journals. He earned his PhD in neurobiology from the State University of New York at Stony Brook and completed postdoctoral work at the NIH and the University of Iowa.

About the University of Maryland Strategic Partnership: MPowering the State

The University of Maryland Strategic Partnership: MPowering the State is a collaboration between the state of Maryland’s two most powerful public research institutions: the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP). It leverages the sizable strengths and complementary missions of both institutions to strengthen Maryland’s innovation economy, advance interdisciplinary research, create opportunities for students, and solve important problems for the people of Maryland and the nation. Working together, UMB and UMCP achieve innovation and impact through collaboration. 

The University of Maryland Strategic Partnership Act of 2016 strengthened and formalized the structured relationship between UMB and UMCP, which began in 2012. The law deepens the alliance and enables UMB and UMCP to pursue even greater transformative change and impact, far surpassing what each institution could do independent of the other. 

About the University of Maryland, Baltimore

The University of Maryland, Baltimore (UMB) was founded in 1807 as the Maryland College of Medicine, which now stands as the nation’s oldest public medical school. In response to growing social and cultural needs, UMB’s mission has evolved and grown tremendously. Widely recognized as a preeminent institution, UMB serves as the academic health, law, and social work university of the University System of Maryland and is guided by a mission of excellence in education, research, clinical care, and public service.

UMB is a thriving academic health center combining cutting-edge biomedical research, exceptional patient care, and nationally ranked academic programs. With extramural funding totaling $654 million in Fiscal Year 2022, each tenured/tenure-track faculty member generates an average of $1.5 million in research grants each year. More than 3,100 faculty members conduct leading-edge research and develop solutions and technologies that impact human health locally and around the world. World-class facilities and cores, as well as interprofessional centers and institutes, allow faculty to investigate pressing questions in a highly collaborative fashion. As a result, the more than 7,000 students, postdocs, and trainees directly benefit from working and learning alongside leading experts as they push the boundaries of their fields.


About the University of Maryland

The University of Maryland (UMD) is the state's flagship university and a leading public research institution, propelled by a $1.3 billion joint research enterprise. Located four miles from Washington, D.C., the university is dedicated to addressing the grand challenges of our time and is the nation's first Do Good campus. It is driven by a diverse and proudly inclusive community of more than 50,000 fearless Terrapins. UMD is a top producer of Fulbright scholars and offers an unparalleled student experience with more than 300 academic programs, 25 living-learning programs and 400 study abroad programs. Spurred by a culture of innovation and creativity, UMD faculty are global leaders in their field and include Nobel laureates, Pulitzer Prize winners and members of the national academies. For more information about the University of Maryland, visit umd.edu.

Tags:

Research

Media Inquiries